11/17/2014 - 11:26am

Pharmaceutical sales through HDMA-member traditional primary distributors reached nearly $305 billion in 2013.

11/17/2014 - 9:54am

Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis. 

11/14/2014 - 9:34am

Walgreens earlier this week opened its first Walgreens Specialty Pharmacy in the Omaha, Neb. market.

 

11/11/2014 - 8:35am

UCB, Advent International and Avista Capital Partners last week announced they have entered into a definitive agreement providing for the acquisition of UCB’s U.S. specialty generics subsidiary, Kremers Urban Pharmaceuticals, by Advent and Avista.

11/06/2014 - 2:46pm

Diplomat Pharmacy on Wednesday announced the addition of Martino Luu to their senior leadership team as VP innovation and process improvement.

 

11/03/2014 - 11:41am

The RAND Corp. projected that the introduction of biosimilar drugs in the United States will reduce direct spending on biologics by $44.2 billion from 2014 to 2024.

 

10/31/2014 - 9:35am

Mylan on Friday announced the launch of nevirapine extended-release tablets in 400-mg strength, a generic version of Viramune XR from Boehringer Ingelheim. 

10/30/2014 - 12:48pm

Sandoz, through its branded dermatology business PharmaDerm, and Medigene AG on Thursday announced a promotion agreement with Women's Choice Pharmaceuticals for Veregen (sinecatechins) ointment, 15% strength. 

10/29/2014 - 12:13pm

The majority of independent community pharmacists are interested in incorporating personalized medicine services into their practices, but they require further education before this is possible.